Position
Fidelity in Apogee Therapeutics, Inc.
Back to the book · All holders of APGE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $121.1M$84.17 → $132.73
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 8.23M | $620.8M | — | — | — | 0.0% |
| Q1 2026 | 9.26M | $779.6M | $84.17 | $71.5M | $87.3M | 0.0% |
| Q2 2026 | 2.49M | $330.9M | $132.73 | $121.1M | −$569.8M | 0.0% |